for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Udg Healthcare PLC

UDG.L

Latest Trade

740.00GBp

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

544.85

 - 

833.00

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
740.00
Open
--
Volume
--
3M AVG Volume
13.56
Today's High
--
Today's Low
--
52 Week High
833.00
52 Week Low
544.85
Shares Out (MIL)
249.33
Market Cap (MIL)
1,851.96
Forward P/E
19.14
Dividend (Yield %)
--

Next Event

Full Year 2019 UDG Healthcare plc Earnings Release

Latest Developments

More

Udg Healthcare Says Reiterates FY Guidance, Q3 Profit "Well Ahead" Of Last Year

UDG Healthcare Raises FY Adj EPS Growth Guidance On A Constant Currency Basis

UDG Healthcare Appoints Myles Lee As Senior Independent Director

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Udg Healthcare PLC

UDG Healthcare PLC is an Ireland-based company that provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 25 countries and delivering services in over 50 countries. The Company operates across two divisions: Ashfield and Sharp. Ashfield provides advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to healthcare companies. Sharp provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries. Sharp operates facilities in the United States and Europe.

Industry

Biotechnology & Drugs

Contact Info

River Walk 20

+353.1.4689000

http://www.udghealthcare.com

Executive Leadership

Peter Gray

Non-Executive Chairman of the Board

Brendan McAtamney

Chief Executive Officer, Executive Director

Nigel Clerkin

Chief Financial Officer, Executive Director

Sean Coyle

Managing Director of Aquilant and Group Finance Director

Doug Burcin

President of Ashfield Healthcare Communications

Key Stats

1.92 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.0K

2017

1.2K

2018

1.3K

2019(E)

1.3K
EPS (USD)

2016

0.390

2017

0.370

2018

0.460

2019(E)

0.482
Price To Earnings (TTM)
90.28
Price To Sales (TTM)
1.78
Price To Book (MRQ)
2.58
Price To Cash Flow (TTM)
26.17
Total Debt To Equity (MRQ)
26.97
LT Debt To Equity (MRQ)
26.97
Return on Investment (TTM)
2.09
Return on Equity (TTM)
1.68

Latest News

BUZZ-UDG Healthcare: Dual acquisitions boosts FY outlook

** Shares of international healthcare services provider UDG Healthcare Plc up 1.6% at 663 pence

Ireland's UDG Healthcare expects rise in full-year profit after first-quarter growth

Ireland-based UDG Healthcare Plc said on Tuesday its first-quarter pretax profit was higher than a year earlier, boosted by gains from its recent acquisitions and growth across its businesses.

UDG Healthcare disappoints on weaker Sharp business

Britain's UDG Healthcare <UDG.L> posted a weaker-than-expected first-half performance at its second-largest business, Sharp, on Tuesday and lowered its outlook for the division, sending its shares down more than 6 percent.

Britain's UDG Healthcare expects 18-21 percent growth in full-year profit

UDG Healthcare <UDG.L> said on Tuesday it expects adjusted earnings per share to increase by 18-21 percent in 2018, driven by a strong trading in the first quarter and gains from the U.S tax reform.

Britain's UDG Healthcare expects 18-21 pct growth in full-year profit

UDG Healthcare said it expects adjusted earnings per share to increase by 18-21 percent in 2018, driven by a strong first-quarter and benefits from the U.S tax reform.

UPDATE 1-UDG Healthcare CFO to retire; profit jumps 17 pct

UDG Healthcare reported a 17 percent increase in full-year earnings on Tuesday, driven mainly by acquisitions, and said Chief Financial Officer Alan Ralph would retire by the end of 2018.

REFILE-UDG Healthcare profit jumps 17 pct; CFO to step down

UDG Healthcare reported a 17 percent increase in full-year earnings on Tuesday, driven mainly by acquisitions, and said Chief Financial Officer Alan Ralph would step down.

BRIEF-UDG Healthcare ‍announces acquisition of US-based healthcare communications agency​

* ANNOUNCES ACQUISITION OF US-BASED HEALTHCARE COMMUNICATIONS AGENCY FOR UP TO $75.8M

BRIEF-UDG Healthcare acquires Cambridge Biomarketing

* Says acquisition of Cambridge Biomarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35 mln

BRIEF-UDG Healthcare ‍acquires Vynamic for up to $32 mln

* Acquisition of Vynamic Llc, a US-based healthcare industry management consulting firm, for total consideration of up to $32 million

UDG Healthcare raises full-year outlook, eyes further deals

UDG Healthcare Plc <UDG.L> could spend up to $600 million (£462.7 million) for acquisitions, its chief executive said, after the company raised its full-year earnings estimate as a recent acquisition helped prop up profit in the first half.

BRIEF-UDG Healthcare appoints Jez Moulding as group COO

* Appoints Jez Moulding as group chief operating officer and executive vice president of Ashfield Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-UDG Healthcare division Sharp expands capacity in the US, UK

* Sharp Packaging Services, a division of UDG Healthcare Plc, announces capacity expansion in US and UK Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-UDG FY profit rises, sees future growth

* Fy diluted earnings per share 1 (eps) from continuing operations increased by 8% (9% on a constant currency basis)

BRIEF-UDG Healthcare updates on Stem Marketing deal

* Confirms issue of 724,997 ordinary shares of eur 0.05 each in company as part of initial consideration for completion of deal of Stem Marketing Ltd Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

BRIEF-UDG Healthcare buys STEM Marketing for 84 mln stg

* UDG healthcare acquires STEM marketing limited for up to 84 mln stg

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up